Nanoencapsulation of olanzapine increases its efficacy in antipsychotic treatment and reduces adverse effects.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Biomedical Nanotechnology

• Publication date

  2014-06-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1166/JBN.2014.1817PMID 24749408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of rheology and release profiles of olanzapine-loaded lipid-core nanocapsules in thermosensitive hydrogel.

  2013cited by this paper
• Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.

  2013cited by this paper
• Acute and subchronic toxicity evaluation of poly(ε-caprolactone) lipid-core nanocapsules in rats.

  2013cited by this paper
• Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.

  2012cited by this paper
• Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine.

  2012cited by this paper
• Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation.

  2012cited by this paper
• Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats.

  2012cited by this paper
• Transport of drugs across the blood-brain barrier by nanoparticles.

  2012cited by this paper
• Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats.

  2011cited by this paper
• Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity.

  2011cited by this paper
• Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats.

  2011cited by this paper
• Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis

  2010cited by this paper
• Aripiprazole attenuates established behavioral sensitization induced by methamphetamine.

  2010cited by this paper
• Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats.

  2010cited by this paper
• A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery.

  2010cited by this paper
• Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model.

  2009cited by this paper
• Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area.

  2009cited by this paper
• Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system.

  2009cited by this paper
• PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation.

  2009cited by this paper
• The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.

  2008cited by this paper
• Medium Chain Triglyceride Oil Consumption as Part of a Weight Loss Diet Does Not Lead to an Adverse Metabolic Profile When Compared to Olive Oil

  2008cited by this paper
• The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities

  2008cited by this paper
• Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.

  2008cited by this paper
• A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs.

  2008cited by this paper
• Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.

  2007cited by this paper
• Atypical Antipsychotic Drugs Directly Impair Insulin Action in Adipocytes: Effects on Glucose Transport, Lipogenesis, and Antilipolysis

  2007cited by this paper
• Modeling madness in mice: one piece at a time.

  2006cited by this paper
• A model for antipsychotic-induced obesity in the male rat

  2006cited by this paper
• Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects

  2006cited by this paper
• Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.

  2006cited by this paper
• Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats

  2005cited by this paper
• D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine

  2005cited by this paper
• Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats.

  2005cited by this paper
• The Effects of Excitotoxic Hippocampal Lesions in Rats on Risperidone- and Olanzapine-Induced Locomotor Suppression

  2002cited by this paper
• Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.

  2001cited by this paper
• Studies of Amphetamine or Methamphetamine Psychosis in Japan: Relation of Methamphetamine Psychosis to Schizophrenia

  2000cited by this paper
• Predicting medication noncompliance after hospital discharge among patients with schizophrenia.

  2000cited by this paper
• Pharmacokinetics and tissue distribution of olanzapine in rats

  1999cited by this paper
• Antipsychotic-induced weight gain: a comprehensive research synthesis.

  1999cited by this paper
• Influence of medium-chain and long-chain triacylglycerols on the control of food intake in men.

  1998cited by this paper
• A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier

  1997cited by this paper
• The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System

  1996cited by this paper
• Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles).

  1995cited by this paper
• Energy expenditure in rats maintained with intravenous or intragastric infusion of total parenteral nutrition solutions containing medium- or long-chain triglyceride emulsions.

  1992cited by this paper
• Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride.

  1982cited by this paper

• Unravelling a potential therapeutic effect of polymeric lipid-core nanoencapsulated cannabidiol on anxiety- and panic-like behaviours elicited by Bothrops jararaca lancehead pit vipers.

  2025cites this paper
• Lipid-core nanocapsules containing simvastatin do not affect the biochemical and hematological indicators of toxicity in rats.

  2024cites this paper
• Applications of innovative technologies to the delivery of antipsychotics.

  2021cites this paper
• Therapeutic benefit of aripiprazole-olanzapine combination in the treatment of senile Alzheimer’s disease complicated by mental disorders

  2020cites this paper
• Transdermal delivery of second-generation antipsychotics for management of schizophrenia; disease overview, conventional and nanobased drug delivery systems

  2020cites this paper
• Controlled Parenteral Formulations: An Efficacious and Favourable Way to Deliver the Anti-psychotic Drugs

  2020cites this paper
• Chitosan-coated nanocapsules ameliorates the effect of olanzapine in prepulse inhibition of startle response (PPI) in rats following oral administration

  2020cites this paper
• Efavirenz-loaded polymeric nanocapsules: Formulation, development, and validation of an RP-UHPLC-DAD method for drug quantification, determination of encapsulation efficiency, stability study, and dissolution profile

  2020cites this paper
• Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations

  2020cites this paper
• Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery

  2019cites this paper
• Antimicrobial and anti-inflammatory drug-delivery systems at endodontic reparative material: Synthesis and characterization.

  2019cites this paper
• Redispersible Spray-Dried Powder Containing Nanoencapsulated Curcumin: the Drying Process Does Not Affect Neuroprotection In vitro

  2019cites this paper
• Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights

  2018cites this paper
• Redispersible spray-dried lipid-core nanocapsules intended for oral delivery: the influence of the particle number on redispersibility

  2018cites this paper
• Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects

  2017cites this paper
• The use of Brazilian vegetable oils in nanoemulsions: an update on preparation and biological applications

  2016cites this paper
• A surface modification of clozapine-loaded nanocapsules improves their efficacy: A study of formulation development and biological assessment.

  2016cites this paper
• Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.

  2016cites this paper
• Production of Isotonic, Sterile, and Kinetically Stable Lipid-Core Nanocapsules for Injectable Administration

  2016cites this paper
• Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.

  2016cites this paper
• Oral nanomedicine approaches for the treatment of psychiatric illnesses.

  2016cites this paper
• Clozapine-Loaded Polysorbate-Coated Polymeric Nanocapsules: Physico-Chemical Characterization and Toxicity Evaluation in Caenorhabditis elegans Model.

  2016cites this paper
• Pre-clinical investigation of the modulation of quetiapine plasma pharmacokinetics and tissues biodistribution by lipid-core nanocapsules.

  2016cites this paper
• Pharmacokinetic Investigation of Quetiapine Transport across Blood-Brain Barrier Mediated by Lipid Core Nanocapsules Using Brain Microdialysis in Rats.

  2016cites this paper
• Nanoencapsulation Improves Relative Bioavailability and Antipsychotic Effect of Olanzapine in Rats.

  2015cites this paper
• Haloperidol-loaded lipid-core polymeric nanocapsules reduce DNA damage in blood and oxidative stress in liver and kidneys of rats

  2015cites this paper
• Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model

  2015cites this paper
• A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies.

  2015cites this paper
• Improving drug biological effects by encapsulation into polymeric nanocapsules.

  2015cites this paper
• Antipsychotic nanomedicine: a successful platform for clinical use.

  2014cites this paper